POSIXACIN

This brand name is authorized in Nigeria.

Active ingredients

The drug POSIXACIN contains one active pharmaceutical ingredient (API):

1	Levofloxacin UNII 6GNT3Y5LMF - LEVOFLOXACIN
	Levofloxacin is a synthetic antibacterial agent of the fluoroquinolone class. As a fluoroquinolone antibacterial agent, levofloxacin acts on the DNA - DNA-gyrase complex and topoisomerase IV.
	Read more about Levofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
07-6236	Tablet	Posixacin Tablets_ TAB 500 mg 1 x 7's	Film-coated Tablet. Orange-coloured, capsule-shaped, biconvex, film-coated tablet with break line on one side and plain on other side. 106 CMS-PP-432635 POSIXACIN TABLETS LEVOFLOXACIN TABLETS Levofloxacin Hemihydrate USP Equivalent to Levofloxacin (500 mg) Excipients: Lactose Monohydrate, Maize Starch, Povidone K-30, Methyl Hydroxybenzoate, Propyl Hydroxybenzoate, Purified Water, Purified Talc, Magnesium Stearate, Croscarmellose sodium, Colloidal Anhydrous Silica, Hypromellose, Titanium Dioxide, Macrogol-6000, Sunset Yellow Lake. 792Jul-36 Drugs Imported Products 1X7 Prescription Only Medicine (POM) 6/19/2024 AFI HEALTH CARE LIMITED, FDL4 PRESIDENTIAL LINE BRIDGE HEAD MARKET ONITSHA, ONITSHA SOUTH LGA ANAMBRA STATE., ONITSHA, Onitsh 8184435083 Afihealth21@gmail.com IMPULSE PHARMA PVT. LTD, J-201, 202/1 TARAPUR MIDC, BOISAR THANE 401506 MAHARASHTRA STATE, INDIA., India	31/07/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA12	Levofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	07-6236